1. Home
  2. BCTXZ

as of 12-12-2025 11:20am EST

$0.42
+$0.06
+17.98%
Stocks Nasdaq

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Chart Type:
Time Range:
Founded: N/A Country:
Canada
Canada
Employees: 4 City: WEST VANCOUVER
Market Cap: N/A IPO Year: N/A
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest BriaCell Therapeutics Corp. Warrant News

BCTXZ Breaking Stock News: Dive into BCTXZ Ticker-Specific Updates for Smart Investing

All BCTXZ News

Share on Social Networks: